Oncternal Therapeutics Inc Capital Reinvestment Ratio

Latest as of March 2008: 0.02x

Oncternal Therapeutics Inc capital reinvestment ratio. Oncternal Therapeutics Inc (ONCT) has a Capital Reinvestment Ratio of 0.02x as of March 2008, meaning it reinvests 0% of its operating cash flow ($28.70 Million) in capital expenditures ($697.00K). Check ONCT cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.02x

Capex / Operating Cash Flow

Operating Cash Flow

$28.70 Million

USD

Capital Expenditures

$697.00K

USD

Data as of

Mar 2008

Most recent filing

Oncternal Therapeutics Inc Capital Reinvestment Ratio by Year (None–None)

Oncternal Therapeutics Inc capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see Oncternal Therapeutics Inc operating cash flow efficiency.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow